Skip to main content

Assessment of ARIA Sufficiency: Briumvi (ublituximab)

    Basic Details
    Approval Date
    Wednesday, December 28, 2022
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes